Augmentation of antipsychotic partial responders with tetrabenazine
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2012
At a glance
- Drugs Tetrabenazine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Jul 2012 Actual end date (1 Jan 2006) added as reported by ClinicalTrials.gov.
- 05 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.